ERFSF OTC
Eurofins Scientific SE
1W: -4.4%
1M: +0.2%
3M: +6.7%
YTD: +15.4%
1Y: +19.6%
3Y: +53.7%
5Y: -33.4%
$85.95
+3.43 (+4.16%)
Weekly Expected Move ±6.5%
$75
$80
$86
$91
$97
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Income Trends
Revenue
$7.3B
+4.9% ▲
5Y CAGR: +6.0%
Gross Profit
$793M
-83.2% ▼
5Y CAGR: -26.5%
Operating Income
$793M
+9.2% ▲
5Y CAGR: -9.3%
Net Income
$475M
+16.8% ▲
5Y CAGR: -2.5%
EPS (Diluted)
$2.54
+21.5% ▲
5Y CAGR: -1.6%
EBITDA
$1.4B
+6.0% ▲
5Y CAGR: +2.6%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $6.7B | $6.7B | $6.5B | $7.0B | $7.3B |
| YoY Growth | +23.5% | -0.1% | -2.9% | +6.7% | +4.9% |
| Cost of Revenue | $2.1B | $2.2B | $5.1B | $2.2B | $6.5B |
| Gross Profit | $4.6B | $4.5B | $1.4B | $4.7B | $793M |
| Gross Margin | 68.0% | 66.8% | 21.1% | 67.8% | 10.9% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $60M | $39M | $136M | $0 | $0 |
| Operating Expenses | $3.3B | $3.7B | $136M | $4.0B | $0 |
| Operating Income | $1.3B | $1.4B | $1.2B | $726M | $793M |
| Operating Margin | 18.8% | 20.6% | 19.0% | 10.4% | 10.9% |
| Interest Expense | $95M | $106M | $129M | $151M | $166M |
| Income Before Tax | $1.1B | $780M | $423M | $555M | $654M |
| Tax Expense | $274M | $174M | $116M | $149M | $181M |
| Net Income | $783M | $610M | $310M | $406M | $475M |
| Net Margin | 11.6% | 9.1% | 4.8% | 5.8% | 6.5% |
| EPS (Diluted) | $3.90 | $3.07 | $1.30 | $2.09 | $2.54 |
| EBITDA | $1.5B | $1.4B | $1.2B | $1.4B | $1.4B |
| Shares Outstanding | 201M | 199M | 198M | 194M | 187M |